Cargando…
Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases
Autores principales: | Manolache, Narcis-George, Ursachi, Vasile, Scohy, Anaïs, Desmet, Charlotte, Yombi, Jean Cyr, Nzeusseu Toukap, Adrien, Stoenoiu, Maria Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673932/ https://www.ncbi.nlm.nih.gov/pubmed/34920024 http://dx.doi.org/10.1016/j.jinf.2021.12.006 |
Ejemplares similares
-
Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies
por: Lambert, Catherine, et al.
Publicado: (2022) -
Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection
por: Choteau, Mathilde, et al.
Publicado: (2022) -
Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
por: De Greef, Julien, et al.
Publicado: (2021) -
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series
por: Fernandes, Guillaume, et al.
Publicado: (2022) -
Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort
por: Dierckx, Stéphanie, et al.
Publicado: (2020)